{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:09:02Z","timestamp":1778310542106,"version":"3.51.4"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Elevated calcium (Ca<jats:sup>2+<\/jats:sup>) levels and hyperactivation of the Ca<jats:sup>2+<\/jats:sup>-dependent phosphatase calcineurin are key factors in \u03b1-synuclein (\u03b1-syn) pathobiology in Dementia with Lewy Bodies and Parkinson\u2019s Disease (PD). Calcineurin activity can be inhibited by FK506, an FDA-approved compound. Our previous work demonstrated that sub-saturating doses of FK506 provide neuroprotection against \u03b1-syn pathology in a rat model of \u03b1-syn neurodegeneration, an effect associated with the phosphorylation of growth-associated protein 43 (GAP-43).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To investigate the role of GAP-43 phosphorylation, we generated phosphomutants at the calcineurin-sensitive sites and expressed them in PC12 cells and primary rat cortical neuronal cultures to assess their effects on neurite morphology and synapse formation. Additionally, we performed immunoprecipitation mass spectrometry in HeLa cells to identify binding partners of these phosphorylation sites. Finally, we evaluated the ability of these phosphomutants to modulate \u03b1-syn toxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, we demonstrate that calcineurin-regulated phosphorylation at S86 and T172 of GAP-43 is a crucial determinant of neurite branching and synapse formation. A phosphomimetic GAP-43 mutant at these sites enhances both processes and provides protection against \u03b1-syn-induced neurodegeneration. Conversely, the phosphoablative mutant prevents neurite branching and synapse formation while exhibiting increased interactions with ribosomal proteins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our findings reveal a novel mechanism by which GAP-43 activity is regulated through phosphorylation at calcineurin-sensitive sites. These findings suggest that FK506\u2019s neuroprotective effects may be partially mediated through GAP-43 phosphorylation, providing a potential target for therapeutic intervention in synucleinopathies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2025.1566465","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:16:48Z","timestamp":1744003008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against \u03b1-synuclein-induced degeneration"],"prefix":"10.3389","volume":"17","author":[{"given":"Ekaterina","family":"Grebenik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Zaichick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Caraveo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-12-802395-2.00024-9","article-title":"Alpha-synucleinopathies.","volume":"145","author":"Alafuzoff","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1083\/jcb.200307098","article-title":"AHNAK interaction with the annexin 2\/S100A10 complex regulates cell membrane cytoarchitecture.","volume":"164","author":"Benaud","year":"2004","journal-title":"J. Cell. Biol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1074\/mcp.M111.013375","article-title":"The induction of serine\/threonine protein phosphorylations by a PDGFR\/TrkA chimera in stably transfected PC12 cells.","volume":"11","author":"Biarc","year":"2012","journal-title":"Mol. Cell Proteomics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.3390\/ijms23084143","article-title":"High eEF1A1 protein levels mark aggressive prostate cancers and the in vitro targeting of eEF1A1 reveals the eEF1A1-actin complex as a new potential target for therapy.","volume":"23","author":"Bosutti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease.","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.1523\/JNEUROSCI.17-18-06939.1997","article-title":"Neuroprotective actions of FK506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism.","volume":"17","author":"Butcher","year":"1997","journal-title":"J. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E3544","DOI":"10.1073\/pnas.1413201111","article-title":"Calcineurin determines toxic versus beneficial responses to \u03b1-synuclein.","volume":"111","author":"Caraveo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E11313","DOI":"10.1073\/pnas.1711926115","article-title":"FKBP12 contributes to \u03b1-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome.","volume":"114","author":"Caraveo","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease.","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1523\/JNEUROSCI.06-12-03618.1986","article-title":"Phosphoprotein F1: Purification and characterization of a brain kinase C substrate related to plasticity.","volume":"6","author":"Chan","year":"1986","journal-title":"J. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12885-020-07728-x","article-title":"Transcriptome profiling unveils GAP43 regulates ABC transporters and EIF2 signaling in colorectal cancer cells.","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1998.0185","article-title":"A novel immunophilin ligand: Distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson\u2019s disease.","volume":"5","author":"Costantini","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.neuron.2013.06.039","article-title":"CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation.","volume":"79","author":"De Rubeis","year":"2013","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/157015906778520782","article-title":"Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43.","volume":"4","author":"Denny","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","article-title":"Calpain-cleavage of alpha-synuclein: Connecting proteolytic processing to disease-linked aggregation.","volume":"170","author":"Dufty","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1083\/jcb.149.7.1443","article-title":"Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity.","volume":"149","author":"Frey","year":"2000","journal-title":"J. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1471-4159.2008.05342.x","article-title":"FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T.","volume":"106","author":"Gerard","year":"2008","journal-title":"J. Neurochem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1096\/fj.05-5126fje","article-title":"The aggregation of alphassynuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy.","volume":"20","author":"Gerard","year":"2006","journal-title":"FASEB J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1523\/JNEUROSCI.5983-09.2010","article-title":"Inhibition of FK506 binding proteins reduces \u03b1-synuclein aggregation and Parkinson\u2019s disease-like pathology.","volume":"30","author":"Gerard","year":"2010","journal-title":"J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF02740664","article-title":"FK506 and the role of immunophilins in nerve regeneration.","volume":"15","author":"Gold","year":"1997","journal-title":"Mol. Neurobiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nn.3209","article-title":"Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson\u2019s disease.","volume":"15","author":"Goldberg","year":"2012","journal-title":"Nat. Neurosci."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.","volume":"73","author":"Greene","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/cdd.2008.188","article-title":"GAP-43 is essential for the neurotrophic effects of BDNF and positive AMPA receptor modulator S18986.","volume":"16","author":"Gupta","year":"2009","journal-title":"Cell Death Differ."},{"key":"B24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fncel.2017.00266","article-title":"Shift from a pivotal to supporting role for the growth-associated protein (GAP-43) in the coordination of axonal structural and functional plasticity.","volume":"11","author":"Holahan","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awt134","article-title":"Parkinson\u2019s disease is associated with altered expression of CaV1 channels and calcium-binding proteins.","volume":"136","author":"Hurley","year":"2013","journal-title":"Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1523\/JNEUROSCI.2270-05.2005","article-title":"Control of dendritic arborization by the phosphoinositide-3\u2019-kinase-Akt-mammalian target of rapamycin pathway.","volume":"25","author":"Jaworski","year":"2005","journal-title":"J. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10357","DOI":"10.1523\/JNEUROSCI.1249-15.2015","article-title":"mRNAs and protein synthetic machinery localize into regenerating spinal cord axons when they are provided a substrate that supports growth.","volume":"35","author":"Kalinski","year":"2015","journal-title":"J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1126\/science.2437653","article-title":"Cloning of complementary DNA for GAP-43, a neuronal growth-related protein.","volume":"236","author":"Karns","year":"1987","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/jnr.21678","article-title":"Characterization of BASP1-mediated neurite outgrowth.","volume":"86","author":"Korshunova","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways.","volume":"25","author":"Kumar","year":"2005","journal-title":"J. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1523\/JNEUROSCI.6785-10.2011","article-title":"BDNF-promoted increases in proximal dendrites occur via CREB-dependent transcriptional regulation of cypin.","volume":"31","author":"Kwon","year":"2011","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e64658","DOI":"10.1371\/journal.pone.0064658","article-title":"A genome-wide screen of CREB occupancy identifies the RhoA inhibitors Par6C and Rnd3 as regulators of BDNF-induced synaptogenesis.","volume":"8","author":"Lesiak","year":"2013","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/neu.10037","article-title":"Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death.","volume":"51","author":"Lesuisse","year":"2002","journal-title":"J. Neurobiol."},{"key":"B35","first-page":"7276407","article-title":"Pilose antler extracts (PAEs) Protect against neurodegeneration in 6-OHDA-Induced Parkinson\u2019s disease rat models.","volume":"2019","author":"Li","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"B36","doi-asserted-by":"crossref","first-page":"12800","DOI":"10.1016\/S0021-9258(18)51557-X","article-title":"Dephosphorylation of neuromodulin by calcineurin.","volume":"264","author":"Liu","year":"1989","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/ncomms1871","article-title":"Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues.","volume":"3","author":"Lundby","year":"2012","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1006\/exnr.1998.6974","article-title":"Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats.","volume":"154","author":"Madsen","year":"1998","journal-title":"Exp. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07576.x","article-title":"\u03b1-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: Relevance to human synucleopathic diseases.","volume":"120","author":"Martin","year":"2012","journal-title":"J. Neurochem."},{"key":"B40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13578-023-01068-6","article-title":"Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson\u2019s disease model.","volume":"13","author":"Mondal","year":"2023","journal-title":"Cell Biosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/j.1471-4159.1990.tb03159.x","article-title":"Mutation of serine 41 in the neuron-specific protein B-50 (GAP-43) prohibits phosphorylation by protein kinase C.","volume":"55","author":"Nielander","year":"1990","journal-title":"J. Neurochem."},{"key":"B42","first-page":"e3965","article-title":"Isolation and culture of rat embryonic neural cells: A quick protocol.","volume":"63","author":"Pacifici","year":"2012","journal-title":"J. Vis. Exp."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","article-title":"BDNF as a promising therapeutic agent in Parkinson\u2019s disease.","volume":"21","author":"Palasz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B44","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nprot.2008.92","article-title":"Generation of human-induced pluripotent stem cells.","volume":"3","author":"Park","year":"2008","journal-title":"Nat. Protoc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1212\/WNL.0b013e3182a55ea5","article-title":"Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation.","volume":"81","author":"Patel","year":"2013","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease.","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bpa.12346","article-title":"Altered expression of growth associated protein-43 and rho kinase in human patients with Parkinson\u2019s disease.","volume":"27","author":"Saal","year":"2017","journal-title":"Brain Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis.","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1158\/0008-5472.CAN-09-4439","article-title":"Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.","volume":"70","author":"Shankar","year":"2010","journal-title":"Cancer Res."},{"key":"B50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3233\/JPD-230313","article-title":"Reduced prevalence of Parkinson\u2019s disease in patients prescribed calcineurin inhibitors.","volume":"14","author":"Silva","year":"2024","journal-title":"JPD"},{"key":"B51","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s007020070079","article-title":"CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.","volume":"107","author":"Sj\u00f6gren","year":"2000","journal-title":"J. Neural Transm (Vienna)."},{"key":"B52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.ne.12.030189.001015","article-title":"Axonal growth-associated proteins.","volume":"12","author":"Skene","year":"1989","journal-title":"Annu. Rev. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1074\/jbc.M115.682161","article-title":"Requirement of neuronal ribosome synthesis for growth and maintenance of the dendritic tree.","volume":"291","author":"Slomnicki","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0896-6273(00)80538-3","article-title":"Immunophilins in the nervous system.","volume":"21","author":"Snyder","year":"1998","journal-title":"Neuron"},{"key":"B55","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1016\/S0021-9258(19)50388-X","article-title":"GAP-43, a protein associated with axon growth, is phosphorylated at three sites in cultured neurons and rat brain.","volume":"267","author":"Spencer","year":"1992","journal-title":"J. Biol. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm0497-421","article-title":"Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A.","volume":"3","author":"Steiner","year":"1997","journal-title":"Nat. Med."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1089\/ars.2010.3521","article-title":"The origins of oxidant stress in Parkinson\u2019s disease and therapeutic strategies.","volume":"14","author":"Surmeier","year":"2010","journal-title":"Antioxid Redox Signal."},{"key":"B58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease.","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","article-title":"Calcium and Parkinson\u2019s disease.","volume":"483","author":"Surmeier","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B60","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2174\/1381612043453135","article-title":"Possibility of non-immunosuppressive immunophilin ligands as potential therapeutic agents for Parkinson\u2019s disease.","volume":"10","author":"Tanaka","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"B61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fnagi.2014.00239","article-title":"Alpha-synuclein mutations impair axonal regeneration in models of Parkinson\u2019s disease.","volume":"6","author":"T\u00f6nges","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40262-018-0717-7","article-title":"Pharmacogenetics of membrane transporters of tacrolimus in solid organ transplantation.","volume":"58","author":"Tron","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","article-title":"Clinical pharmacokinetics of tacrolimus.","volume":"29","author":"Venkataramanan","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12035-012-8332-3","article-title":"The neuroprotective effect of overexpression of calbindin-D(28k) in an animal model of Parkinson\u2019s disease.","volume":"47","author":"Yuan","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1292555","DOI":"10.3389\/fmolb.2023.1292555","article-title":"Harnessing IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in \u03b1-synucleinopathies.","volume":"10","author":"Zaichick","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"B66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000063254","article-title":"Effect of FK506 on neurotransmitter content and expression of GAP-43 in neurotoxin-lesioned peripheral sensory and sympathetic neurons.","volume":"66","author":"Zuber","year":"2002","journal-title":"Pharmacology"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1566465\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:17:26Z","timestamp":1744003046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1566465\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":66,"alternative-id":["10.3389\/fnagi.2025.1566465"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1566465","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"article-number":"1566465"}}